Cargando…

Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and the Implications of New Biomarkers

Detalles Bibliográficos
Autor principal:	Schöffski, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970819/ https://www.ncbi.nlm.nih.gov/pubmed/35831106 http://dx.doi.org/10.2169/internalmedicine.0379-22

Ejemplares similares

Complete Response to Eribulin in a Patient with Unresectable Liposarcoma: A Case Report and Implications of New Biomarkers
por: Nakamura, Hajime, et al.
Publicado: (2022)

Eribulin Approval in Advanced Liposarcoma – Successful Drug or a Weaker Methodology?
por: Rastogi, Sameer, et al.
Publicado: (2017)

Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma
por: Tamiya, Hironari, et al.
Publicado: (2020)

Eribulin in Patients with Liposarcoma and Leiomyosarcoma: A Retrospective Single-Center Experience
por: Steinbrecher, Oskar, et al.
Publicado: (2023)

Occurrence of colonic liposarcoma after retroperitoneal liposarcoma
por: Choi, Jin Hwa, et al.
Publicado: (2015)

Conglomerated Facial Liposarcoma
por: Shin, Jaeyoung, et al.
Publicado: (2013)

New-onset heart failure masking a massive retroperitoneal liposarcoma
por: Rivas Rios, Jose, et al.
Publicado: (2022)

Intrathoracic liposarcoma: Case report with emphasis to histogenesis and site of origin classification problems
por: Pusiol, Teresa, et al.
Publicado: (2018)

Primary intrathoracic liposarcoma: a clinical analysis of 31 cases
por: Fu, Zhixue, et al.
Publicado: (2019)

A huge primary pleomorphic liposarcoma of the left atrium
por: Plicner, Dariusz, et al.
Publicado: (2017)

Unresectable gastrointestinal stromal tumors
por: Menon, Prema, et al.
Publicado: (2011)

A liquid biopsy signature predicts treatment response to fluoropyrimidine plus platinum therapy in patients with metastatic or unresectable gastric cancer: implications for precision oncology
por: Lee, In-Seob, et al.
Publicado: (2022)

Systemic Therapy in Metastatic or Unresectable Well-Differentiated/Dedifferentiated Liposarcoma
por: McGovern, Yevette, et al.
Publicado: (2017)

Recurrent paratesticular dedifferentiated liposarcoma after contralateral radical orchiectomy
por: Wang, Jin, et al.
Publicado: (2018)

Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
por: Dhumal, Sachin, et al.
Publicado: (2019)

Validating a gene expression signature proposed to differentiate liposarcomas that use different telomere maintenance mechanisms
por: Doyle, K R, et al.
Publicado: (2012)

Case report and literature review: Conversion surgery for initially unresectable huge retroperitoneal liposarcoma after preoperative radiotherapy
por: Cheng, Sarah Hsin, et al.
Publicado: (2023)

Malignant Adenomyoepithelioma of the Breast and Responsiveness to Eribulin
por: Lee, Suee, et al.
Publicado: (2015)

Long lasting complete response with immunotherapy in a metastatic bladder carcinoma: a case report
por: Magalhães, Denise S.T., et al.
Publicado: (2021)

Ongoing under-reporting of clinically relevant safety data in phase II studies of tyrosine kinase inhibitors
por: Schöffski, P, et al.
Publicado: (2010)

Octreotide in Palliative Treatment of Unresectable Cholangiocarcinoma: Is it Effective for Disease Stabilization?
por: Pistevou-Gompaki, Kiki, et al.
Publicado: (2008)

Unresectable cardiac paraganglioma – a rare case of clinically malignant tumor in an 8-year-old girl
por: Kołcz, Jacek, et al.
Publicado: (2019)

Eribulin versus dacarbazine in patients with leiomyosarcoma: subgroup analysis from a phase 3, open-label, randomised study
por: Blay, Jean-Yves, et al.
Publicado: (2019)

Immune combinations and complete response: a new hope for metastatic renal cell carcinoma
por: Catalano, Martina, et al.
Publicado: (2022)

Targeted next-generation sequencing of circulating free DNA enables non-invasive tumor detection in myxoid liposarcomas
por: Eisenhardt, A. E., et al.
Publicado: (2022)

Efficacy of eribulin in breast cancer: a short report on the emerging new data
por: Eslamian, Gelareh, et al.
Publicado: (2017)

Anesthetic considerations during heart-lung transplantation in a patient with an unresectable pulmonary artery sarcoma
por: Bae, Heon-Yong, et al.
Publicado: (2012)

Long-term survival outcomes of technically unresectable carcinoma maxilla postinduction chemotherapy
por: Dhumal, Sachin Babanrao, et al.
Publicado: (2018)

A rare case of pinealoblastoma in adult with complete response to treatment
por: Patel, Amrith, et al.
Publicado: (2018)

Eribulin drug review
por: Shetty, Nishitha, et al.
Publicado: (2014)

Eribulin in Cancer Treatment
por: Swami, Umang, et al.
Publicado: (2015)

A case of asymptomatic complete tracheal rings in an adult: case report
por: Hayasaka, Tomoko, et al.
Publicado: (2019)

Reply to comments on “Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei”
por: Hiraide, Sakura, et al.
Publicado: (2021)

Complete metabolic response after Partially Ablative Radiotherapy (PAR) for bulky retroperitoneal liposarcoma: A case report
por: Medici, Federica, et al.
Publicado: (2023)

GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells
por: Bellio, Chiara, et al.
Publicado: (2022)

Eribulin in the Management of Advanced Breast Cancer: Implications of Current Research Findings
por: Kok, Victor C.
Publicado: (2015)

Immune Checkpoint Inhibitor-Related Pneumonia in Unresectable Hepatocellular Carcinoma: Two Fatal Cases under Atezolizumab plus Bevacizumab
por: Endo, Kei, et al.
Publicado: (2022)

Feasibility and safety of EUS-guided radiofrequency ablation in treatment of locally advanced, unresectable pancreatic cancer
por: Jiang, Jieling, et al.
Publicado: (2021)

Development of interstitial pneumonia during treatment with eribulin: a case report
por: Nakamura, Kota, et al.
Publicado: (2017)

Is adjuvant immunotherapy a new standard for non‐pathological complete response patients with resectable esophageal squamous cell carcinoma?
por: Wang, Jun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_337icqqovvtvapkpj289ah855r